GuruFocus.com
Earnings To Watch: PROCEPT BioRobotics Corp (PRCT) Reports Q4 2025 Result
➖
AI Sentiment
Neutral
4/10
- Home
- PRCT
as of 02-24-2026 9:34am EST
$27.32
$0.04
-0.16%
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | SAN JOSE |
| Market Cap: | 1.8B | IPO Year: | 2021 |
| Target Price: | $51.13 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.19 | EPS Growth: | 21.88 |
| 52 Week Low/High: | $26.23 - $70.80 | Next Earning Date: | 01-01-0001 |
| Revenue: | $224,498,000 | Revenue Growth: | 64.84% |
| Revenue Growth (this year): | 48.3% | Revenue Growth (next year): | 29.44% |
| P/E Ratio: | -23.01 | Index: | N/A |
| Free Cash Flow: | -103622000.0 | FCF Growth: | N/A |
Latest PROCEPT BioRobotics Corporation News
PRCT Breaking Stock News: Dive into PRCT Ticker-Specific Updates for Smart Investing
Compare PRCT vs Leading Stocks
See how PRCT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PRCT PROCEPT BioRobotics Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.